Published October 15, 2026 | Version 1.1.0

Metabolite-aware pharmacokinetic forgiveness analysis of imatinib in chronic myeloid leukemia: analysis code and simulated result datasets

  • 1. Department of Pharmacology, All India Institute of Medical Sciences (AIIMS) Bhubaneswar, India

Description

Analysis code and generated result datasets for a metabolite-aware pharmacokinetic simulation of missed imatinib doses in chronic myeloid leukemia. A literature-assembled two-compartment parent model coupled to the active metabolite N-desmethyl-imatinib (CGP74588) is used to test whether the metabolite increases imatinib's pharmacokinetic forgiveness of missed doses at 400 and 600 mg once daily.

Version 1.1.0 (revision in response to peer review) makes the analysis restricted to patients at target primary, adds trajectory-based endpoints and exposure headroom, benchmarks the framework against three published parent-metabolite population models, and extends the sensitivity analyses (metabolite structure and half-life, saturable formation, variability, late intake, random adherence, target sweep, sourced parameter uncertainty). Version 1.0.0 reproduces the originally submitted analysis.

The analysis is fully deterministic under fixed random seeds: Rscript R/run_all.R regenerates every reported value, table and figure.

Files

abhitrades67-coder/imatinib-forgiveness-v1.1.0.zip

Files (102.6 MB)

Name Size
md5:c7c26210ef6460b8500269c894a3709f
102.6 MB Preview Download

Additional details